Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Congenital Factor VIII (FVIII) Deficiency”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Post-approval studies (Phase 4)Looking for participantsNCT04567511
What this trial is testing

Hemlibra in Mild Hemophilia A

Who this might be right for
Factor VIII Deficiency, Congenital
Indiana Hemophilia &Thrombosis Center, Inc. 20
Not applicableStudy completedNCT00002276
What this trial is testing

The Effects of AZT and Ibuprofen on HIV-Infected Patients With Hemophilia

Who this might be right for
HIV InfectionsHemophilia A
University of Pittsburgh
Not applicableStudy completedNCT02093741
What this trial is testing

ADVATE 2 mL Post-Authorization Safety Surveillance (PASS)

Who this might be right for
Hemophilia ACongenital Factor VIII (FVIII) Deficiency
Baxalta now part of Shire 65
Not applicableStudy completedNCT03876301
What this trial is testing

Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants

Who this might be right for
Blood Coagulation DisorderBlood Coagulation Disorders, InheritedCoagulation Protein Disorders+6 more
Spark Therapeutics, Inc. 25
Testing effectiveness (Phase 2)Study completedNCT03734588
What this trial is testing

Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors

Who this might be right for
Adeno-Associated Virus (AAV)Blood Coagulation DisorderBlood Coagulation Disorders, Inherited+14 more
Spark Therapeutics, Inc. 4
Testing effectiveness (Phase 2)Study completedNCT00055341
What this trial is testing

Treatment of Hepatitis C in Hemophilic Patients With HIV

Who this might be right for
HIV InfectionsHepatitis CHemophilia
National Institute of Allergy and Infectious Diseases (NIAID) 22
Not applicableLooking for participantsNCT06684314
What this trial is testing

Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A in Taiwan

Who this might be right for
Hemophilia A
Sanofi 100
Not applicableStudy completedNCT05517070
What this trial is testing

Vitamin D Deficiency and Body Composition in the Patients With Hemophilia

Who this might be right for
Vitamin D DeficiencySarcopeniaOsteoporosis+3 more
Tsung-Ying Li 80
Large-scale testing (Phase 3)Study completedNCT04161495
What this trial is testing

Open-label Interventional Study of Intravenous Recombinant Coagulation Factor VIII Fc-von Willebrand Factor-XTEN Fusion Protein, Efanesoctocog Alfa (BIVV001), in Patients With Severe Hemophilia A

Who this might be right for
Factor VIII Deficiency
Bioverativ, a Sanofi company 159
Large-scale testing (Phase 3)Study completedNCT01178294
What this trial is testing

Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Acquired Hemophilia A

Who this might be right for
Acquired Hemophilia A
Baxalta now part of Shire 29
Not applicableStudy completedNCT04165135
What this trial is testing

An Observational Study to Evaluate Physical Activity, Bleeding Incidence and Health Related Quality of Life, in Participants With Haemophilia A Without Inhibitors Receiving Standard of Care Treatment

Who this might be right for
Severe Hereditary Factor VIII Deficiency Disease Without InhibitorModerate Hereditary Factor VIII Deficiency Disease Without InhibitorHaemophilia A
Hoffmann-La Roche 103
Large-scale testing (Phase 3)Study completedNCT00162019
What this trial is testing

Pharmacokinetics, Efficacy and Safety Study of IMMUNATE SD (Human Plasma-Derived Coagulation Factor VIII Concentrate) in Hemophilia A Patients

Who this might be right for
Hemophilia A
Baxalta now part of Shire 56
Not applicableUnknownNCT06014320
What this trial is testing

Alterations in Coagulation Factor Levels in Patients With End Stage Liver Disease

Who this might be right for
Liver CirrhosisHemophiliaHemophilia A+4 more
Stanford University 25
Not applicableStudy completedNCT06020456
What this trial is testing

Genetic Factors of the Desmopressin Response in Carriers of Hemophilia A

Who this might be right for
Carrier of Hemophilia ADesmopressinFactor VIII Deficiency
Groupe Maladies hémorragiques de Bretagne 361
Not applicableEnded earlyNCT00340548
What this trial is testing

Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)

Who this might be right for
HemophiliaAIDS
National Cancer Institute (NCI) 333
Post-approval studies (Phase 4)Study completedNCT00002386
What this trial is testing

Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia

Who this might be right for
HIV InfectionsHemophilia A
Merck Sharp & Dohme LLC 55
Not applicableLooking for participantsNCT07314983
What this trial is testing

Long-term Anticoagulation in a Patient With Severe Hemophilia A

Who this might be right for
Hemophilia A
University Hospital, Strasbourg, France 1
Not applicableLooking for participantsNCT07414511
What this trial is testing

Hemophilia A Research Program

Who this might be right for
Hemophilia AHemophilia A, SevereFactor VIII (FVIII)+10 more
University of Washington 500
Not applicableStudy completedNCT01000844
What this trial is testing

Joint Outcome Study Continuation for Children With Severe Factor VIII Deficiency

Who this might be right for
Hemophilia
University of Colorado, Denver 11
Large-scale testing (Phase 3)Study completedNCT00189982
What this trial is testing

Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients in Canada With Hemophilia A - A Continuation of Baxter Study 060101

Who this might be right for
Hemophilia A
Baxalta now part of Shire 4
Load More Results